Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Cooper

Showing results (41-50 of 246) with videos related to

Pageof 25
Sort By:
Metabolism: Clinical and Experimental|December 29, 1998
Pathophysiology of diabetic nephropathyM E Cooper, R E Gilbert, M Epstein
Drug Safety|June 25, 1998
Drug administration in patients with diabetes mellitus. Safety considerationsR E Gilbert, M E Cooper, H Krum
Clinical and Experimental Pharmacology & Physiology|October 7, 1997
Diabetic vascular complicationsM E Cooper, R E Gilbert, G Jerums
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|February 24, 2007
Diabetic nephropathy: where hemodynamics meets metabolismJ M Forbes, K Fukami, M E Cooper
The Australian and New Zealand Journal of Surgery|November 1, 1996
Effects of liver transplantation and resection on lipid parameters: a longitudinal studyM E Cooper, A Akdeniz, K J Hardy
Microvascular Research|January 12, 1999
Cellular mechanisms of diabetic vascular hypertrophyD Vranes, M E Cooper, R J Dilley
Mineral and Electrolyte Metabolism|February 4, 1999
Interaction of the renal amylin and renin-angiotensin systems in animal models of diabetes and hypertensionP J Wookey, Z Cao, M E Cooper
The International Journal of Biochemistry & Cell Biology|October 4, 2005
Role of the renin-angiotensin system in the endocrine pancreas: implications for the development of diabetesC Tikellis, M E Cooper, M C Thomas
The Journal of Pharmacy and Pharmacology|June 1, 1979
The determination of aluminium in antacid formulations by Gran's Plot titration with sodium fluorideM E Cooper, J Ballantine, A D Woolfson
Blood Pressure|November 1, 1995
Diabetes and hypertension: prognostic and therapeutic considerationsR E Gilbert, G Jerums, M E Cooper
Pageof 25

Showing results (41-50 of 246) with videos related to

Sort By:
Pageof 25
Metabolism: Clinical and Experimental|December 29, 1998
Pathophysiology of diabetic nephropathyM E Cooper, R E Gilbert, M Epstein
Drug Safety|June 25, 1998
Drug administration in patients with diabetes mellitus. Safety considerationsR E Gilbert, M E Cooper, H Krum
Clinical and Experimental Pharmacology & Physiology|October 7, 1997
Diabetic vascular complicationsM E Cooper, R E Gilbert, G Jerums
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|February 24, 2007
Diabetic nephropathy: where hemodynamics meets metabolismJ M Forbes, K Fukami, M E Cooper
The Australian and New Zealand Journal of Surgery|November 1, 1996
Effects of liver transplantation and resection on lipid parameters: a longitudinal studyM E Cooper, A Akdeniz, K J Hardy
Microvascular Research|January 12, 1999
Cellular mechanisms of diabetic vascular hypertrophyD Vranes, M E Cooper, R J Dilley
Mineral and Electrolyte Metabolism|February 4, 1999
Interaction of the renal amylin and renin-angiotensin systems in animal models of diabetes and hypertensionP J Wookey, Z Cao, M E Cooper
The International Journal of Biochemistry & Cell Biology|October 4, 2005
Role of the renin-angiotensin system in the endocrine pancreas: implications for the development of diabetesC Tikellis, M E Cooper, M C Thomas
The Journal of Pharmacy and Pharmacology|June 1, 1979
The determination of aluminium in antacid formulations by Gran's Plot titration with sodium fluorideM E Cooper, J Ballantine, A D Woolfson
Blood Pressure|November 1, 1995
Diabetes and hypertension: prognostic and therapeutic considerationsR E Gilbert, G Jerums, M E Cooper
Pageof 25